Lifestar Pharma LLC, announces the launch of Bimatoprost Ophthalmic Solution 0.01%, the first generic equivalent to LUMIGAN® Learn More
Lifestar capabilities range from product development to manufacturing to commercialization, and is open to discuss and collaborate any opportunities that would create value to all stakeholders.
Strategic
Collaborations
Co-Development & In-Licensing
Lifestar, to complement our in-house development programs, is interested in partnering with organizations that leverage their expertise in development of complex multisource products. We bring to the table a strong Product Selection, Technical, IP, Regulatory and Financial expertise with a commitment to partnership.
ANDA / 505(b)(2) / NDA Acquisition
Lifestar is actively pursuing opportunities to acquire ANDAs, 505(b)(2)s and NDAs that are strategically aligned with our business plan.
Marketing & Selling
Lifestar has built strong commercialization capabilities and is in a position to take on Marketing , Selling and Distribution arrangements for ANDA and Authorized Generic products.